BMS-863233

· Bristol-Myers Squibb

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for BMS-863233, covering 2015-10-12 to 2023-04-28. Get the full timeline:

Most recent: Clinical Trial Update: A Study of BMS-863233 in Patients With Advanced and/or Metastatic Solid Tumors [Phase 1, Phase 2]